Published in World Neurosurg on August 15, 2011
Radiosurgery for high-grade glioma. Surg Neurol Int (2012) 0.81
Recurrent malignant gliomas. Semin Radiat Oncol (2014) 0.79
Salvage radiosurgery for selected patients with recurrent malignant gliomas. Biomed Res Int (2014) 0.79
Clinical outcomes following salvage Gamma Knife radiosurgery for recurrent glioblastoma. World J Clin Oncol (2014) 0.78
Stereotactic Radiosurgery for Glioblastoma. Cureus (2015) 0.78
External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastoma. Expert Rev Anticancer Ther (2016) 0.78
Indications and Efficacy of Gamma Knife Stereotactic Radiosurgery for Recurrent Glioblastoma: 2 Decades of Institutional Experience. Neurosurgery (2016) 0.77
Radiosurgery reirradiation for high-grade glioma recurrence: a retrospective analysis. Neurol Sci (2015) 0.76
Recurrent Glioblastoma: Where we stand. South Asian J Cancer (2016) 0.75
Re-irradiation alternatives for recurrent high-grade glioma. Oncol Lett (2016) 0.75
Re-irradiation after gross total resection of recurrent glioblastoma : Spatial pattern of recurrence and a review of the literature as a basis for target volume definition. Strahlenther Onkol (2017) 0.75
MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma. J Neurooncol (2017) 0.75
Transforming fusions of FGFR and TACC genes in human glioblastoma. Science (2012) 5.09
Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol (2004) 3.56
Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology (2008) 2.83
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol (2005) 2.24
C2 nerve root sectioning in posterior C1-2 instrumented fusions. World Neurosurg (2011) 2.23
Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys (2005) 2.04
Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys (2007) 1.91
Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas. AJNR Am J Neuroradiol (2003) 1.83
High-grade glioma before and after treatment with radiation and Avastin: initial observations. Neuro Oncol (2008) 1.61
A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma. J Neurosurg (2011) 1.52
Resection of insular gliomas: the importance of lenticulostriate artery position. J Neurosurg (2008) 1.48
A comparison of survival rates for treatment of melanoma metastatic to the brain. Cancer Invest (2004) 1.46
A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2006) 1.39
Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β. Cancer Res (2012) 1.34
Clinical outcomes of postmastectomy radiation therapy after immediate breast reconstruction. Int J Radiat Oncol Biol Phys (2008) 1.33
Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys (2007) 1.33
Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: long-term outcomes and predictors of response. Epilepsy Behav (2010) 1.23
R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma. Acta Neuropathol (2010) 1.22
Feasibility of using bevacizumab with radiation therapy and temozolomide in newly diagnosed high-grade glioma. Int J Radiat Oncol Biol Phys (2008) 1.17
Prevention and management of cerebrospinal fluid leak following vestibular schwannoma surgery. Laryngoscope (2004) 1.16
Therapeutic targets in malignant glioblastoma microenvironment. Semin Radiat Oncol (2009) 1.11
Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol (2012) 1.10
Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum--use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI. AJR Am J Roentgenol (2012) 1.10
Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery. Melanoma Res (2013) 1.08
Geometric factors influencing dosimetric sparing of the parotid glands using IMRT. Int J Radiat Oncol Biol Phys (2006) 1.04
Decreased risk of wound infection after posterior cervical fusion with routine local application of vancomycin powder. Spine (Phila Pa 1976) (2013) 0.99
Prospective neuraxis MRI surveillance reveals a high risk of leptomeningeal dissemination in diffuse intrinsic pontine glioma. J Neurooncol (2010) 0.99
Vemurafenib and radiation therapy in melanoma brain metastases. J Neurooncol (2013) 0.96
Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer. Int J Radiat Oncol Biol Phys (2005) 0.96
Diagnostic sensitivity of serum and lumbar CSF bHCG in newly diagnosed CNS germinoma. Pediatr Blood Cancer (2012) 0.94
Image-fusion of MR spectroscopic images for treatment planning of gliomas. Med Phys (2006) 0.94
A multicenter, single-blind, prospective randomized trial to evaluate the safety of a polyethylene glycol hydrogel (Duraseal Dural Sealant System) as a dural sealant in cranial surgery. World Neurosurg (2011) 0.91
Endovascular solutions to arterial injury due to posterior spine surgery. J Vasc Surg (2011) 0.91
Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol (2013) 0.90
Auditory brainstem implantation in patients with neurofibromatosis type 2. Laryngoscope (2004) 0.90
Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study. J Neurosurg (2013) 0.89
A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931). Int J Radiat Oncol Biol Phys (2009) 0.89
Accuracy and feasibility of cone-beam computed tomography for stereotactic radiosurgery setup. Med Phys (2007) 0.89
Retrolabyrinthine craniectomy: the unsung hero of skull base surgery. Skull Base (2004) 0.88
Results of surgical resection for progression of brain metastases previously treated by gamma knife radiosurgery. Neurosurgery (2006) 0.86
Patterns of failure in supratentorial primitive neuroectodermal tumors treated in Children's Cancer Group Study 921, a phase III combined modality study. Int J Radiat Oncol Biol Phys (2004) 0.86
Epilepsy surgery and tuberous sclerosis complex: special considerations. Neurosurg Focus (2008) 0.86
Central nervous system cancers: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2005) 0.85
Importance of MR technique for stereotactic radiosurgery. Neuro Oncol (2003) 0.84
Glioma vascularity correlates with reduced patient survival and increased malignancy. Surg Neurol (2009) 0.83
Phase I/II trial of induction chemotherapy followed by concurrent chemoradiotherapy and surgery for locoregionally advanced pancreatic cancer. Ann Surg Oncol (2008) 0.83
Bilateral invasive electroencephalography in patients with tuberous sclerosis complex: a path to surgery? J Neurosurg Pediatr (2011) 0.83
Patterns of treatment failure in infants with primitive neuroectodermal tumors who were treated on CCG-921: a phase III combined modality study. Pediatr Blood Cancer (2005) 0.82
A panoramic view of the skull base: systematic review of open and endoscopic endonasal approaches to four tumors. Pituitary (2014) 0.81
Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants. J Neurosurg (2011) 0.81
Incidence, timing, and treatment of new brain metastases after Gamma Knife surgery for limited brain disease: the case for reducing the use of whole-brain radiation therapy. J Neurosurg (2011) 0.81
Minimal residual calcification and recurrence after gross-total resection of craniopharyngioma in children. J Neurosurg Pediatr (2009) 0.81
Neurological complications and symptom resolution following Gamma Knife surgery for brain metastases 2 cm or smaller in relation to eloquent cortices. J Neurosurg (2010) 0.81
Challenging the current paradigm of melanoma progression: brain metastasis as isolated first visceral site. Neuro Oncol (2012) 0.81
Effect of MLC leaf width and PTV margin on the treatment planning of intensity-modulated stereotactic radiosurgery (IMSRS) or radiotherapy (IMSRT). Med Dosim (2008) 0.81
Resection of parietal lobe gliomas: incidence and evolution of neurological deficits in 28 consecutive patients correlated to the location and morphological characteristics of the tumor. J Neurosurg (2005) 0.81
Cranial nerve preservation in surgery for large acoustic neuromas. Skull Base (2004) 0.80
Posterior fossa meningiomas presenting with Ménière's-like symptoms: case report. Neurosurgery (2008) 0.80
Local control of newly diagnosed and distally recurrent, low-volume brain metastases with fixed-dose (20 gy) gamma knife radiosurgery. Neurosurgery (2011) 0.80
Feasibility study of intensity-modulated radiotherapy (IMRT) treatment planning using brain functional MRI. Med Dosim (2008) 0.80
Magnetic resonance spectroscopy imaging (MRSI) and brain functional magnetic resonance imaging (fMRI) for radiotherapy treatment planning of glioma. Technol Cancer Res Treat (2008) 0.80
Lumbar laminectomy and fusion with routine local application of vancomycin powder: decreased infection rate in instrumented and non-instrumented cases. Clin Neurol Neurosurg (2013) 0.80
Surgical treatment of ectopic recurrence of craniopharyngioma. Report of 4 cases. J Neurosurg Pediatr (2009) 0.80
Development and characterization of a clinically relevant mouse model of melanoma brain metastasis. Pigment Cell Melanoma Res (2013) 0.79
Functional MRI for radiotherapy of gliomas. Technol Cancer Res Treat (2010) 0.79
Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma. Ann Surg Oncol (2011) 0.79
Management of surgical complications and failures in acoustic neuroma surgery. Otolaryngol Clin North Am (2012) 0.78
Dynamic susceptibility contrast-enhanced perfusion and conventional MR imaging findings for adult patients with cerebral primitive neuroectodermal tumors. AJNR Am J Neuroradiol (2004) 0.78
Impact of failed intracranial epilepsy surgery on the effectiveness of subsequent vagus nerve stimulation. Neurosurgery (2011) 0.78
Occipital transtentorial approach to the precentral cerebellar fissure and posterior incisural space. Neurosurgery (2009) 0.78
Involved field radiation therapy after surgical resection of solitary brain metastases--mature results. Neuro Oncol (2013) 0.78
Plaque radiotherapy for choroidal and ciliochoroidal melanomas with limited nodular extrascleral extension. Can J Ophthalmol (2004) 0.78
Small vestibular schwannomas with no hearing: comparison of functional outcomes in stereotactic radiosurgery and microsurgery. Laryngoscope (2008) 0.77
Refractory epilepsy in tuberous sclerosis: vagus nerve stimulation with or without subsequent resective surgery. Epilepsy Behav (2009) 0.77
Successful management of an anterior thoracic Type IV spinal arteriovenous malformation with two associated aneurysms utilizing vertebrectomy. Technical note. J Neurosurg Spine (2008) 0.77
Role of HER2 status in the treatment for brain metastases arising from breast cancer with stereotactic radiosurgery. Med Oncol (2014) 0.76